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CTL it f FMDV d t i d b thep opes o e erm ne y e      
N tMHC d i di ti f SLA/ tid bi di fi d b t te pan r ven pre c ons o pep e n ng con rme y e ramer-     ,   
l f ti d t i icomp ex orma on an s a n ng   
Lasse E Pedersen1 2 3 Morten Nielsen4 Jared R Patch1 Gregers Jungersen2 Søren Buus3 and William T Golde1, ,  . ,  ,  . ,  ,  ,   . 
1 F i A i l Di U it Pl I l d A i l Di C t A i lt l R h S i USDA O i t P i t NY USAore gn n ma sease n um s an n ma sease en er gr cu ura esearc erv ce r en o n   ,    ,   , ,  , , 
2National Veterinary Institute Technical University of Denmark Copenhagen Denmark, , ,        
3L b t f E i t l I l F lt f H lth S i U i it f C h C h D ka ora ory o xper men a mmuno ogy acu y o ea c ences n vers y o open agen open agen enmar   ,    ,   , , 
4C t f Bi l i l S A l i T h i l U i it f D k C h D ken er or o og ca equence na ys s ec n ca n vers y o enmar open agen enmar    ,    , , 
P 066- The A24 FMDV P1 region SLA tetramer       
productionAb t ts rac
GAGQSSPATGSQNQSGNTGSIINNYYMQQYQNSMDTQLGDNAISGGSNE
GSTDTTSTHTTNTQNNDWFSKLASSAFTGLFGALLADKKTEETTLLEDRITo date little has been reported about porcine T cell epitopes during viral LTTRNGHTTSTTQSSVGVTHGYSTEEDHVAGPNTSGLETRVVQAERFYKK
disease In this study we describe the application of a state of the art YLFDWTTDKAFGHLEKLELPSDHHGVFGHLVDSYAYMRNGWDVEVSAVGN. , - - -
QFNGGCLLVAMVPEWKEFDTREKYQLTLFPHQFISPRTNMTAHITVPYLGMHC/peptide predictor algorithm developed for Human Leukocyte Antigen
VNRYDQYKKHKPWTLVVMVVSPLTVNNTSAAQIKVYANIAPTYVHVAGEL(HLA) Class I genes NetMHCpan To analyze Swine Leukocyte Antigen, . PSKEGIFPVACADGYGGLVTTDPKTADPAYGKVYNPPRTNYPGRFTNLLD
(SLA) molecules SLA 1*0401 and SLA 2*0401 we used closely related HLA VAEACPTFLCFDDGKPYVTTRTDDTRLLAKFDLSLAAKHMSNTYLSGIAQ- - ,
C f f YYTQYSGTINLHFMFTGSTDSKARYMVAYIPPGVETPPDTPERAAHCIHAlass I molecules in the database to identi y potential peptide epitopes rom
EWDTGLNSKFTFSIPYVSAADYAYTASDTAETINVQGWVCIYQITHGKAEh P1/ id i i f f d h di i (FMDV) it e caps prote n reg on o oot-an -mout sease v rus stra n NDTLVVSVSAGKDFELRLPIDPRQQTTATGESADPVTTTVENYGGETQIQ
A24 N tMHC di t d i ibl 9 d 10 tide pan pre c e n ne poss e mer an mer pep e RRHHTDIGFIMDRFVKIQSLSPTHVIDLMQTHQHGLVGALLRAATYYFSD.
th t ld bi d SLA 1*0401 d t f SLA 2*0401 ith i f LEIVVRHEGNLTWVPNGAPESALLNTSNPTAYNKAPFTRLALPYTAPHRVsequences a wou n - an en or - w n ne o,
LATVYNGTSKYAVGGSGRRGDMGSLAARVVKQLPASFNYGAIKADAIHEL
t di t d t bi d b th l l I tid d d t fen pre c e o n o mo ecu es n a pep e epen en assay or LVRMKRAELYCPRPLLAIEVSSQDRHKQKIIAPAKQ.
MHC tid l f ti ith bi t SLA t i fi f th
 
-pep e comp ex orma on w recom nan pro e ns ve o e,
di t d tid b d SLA 1*0401 t i ifi t bi di ffi iti dpre c e pep es oun - a s gn can n ng a n es an
f tid b d SLA 2*0401 H i id tifi d th FMDV tidour pep es oun - av ng en e ese pep es.
ith t ti l f b i it f T ll t i t d t th t SLAw po en a or e ng ep opes or ce s res r c e o ese wo Tetramer production figure taken from: Rodenko B M Toebes S Reker HadrupNetMHCpan predictions and actual ELISA peptide binding      , ., . , .  , 
l l d t t f MHC tid l i l W J E E h A M M l T N M S h h & H O (2006) G ti
      
mo ecu es we prepare e ramers o -pep e comp exes as prev ous y van sc o enaar c umac er vaa enera on, . . .  , . . , . . .   . .   
d ib d f h S i h f SLA 1*0401 d SLA of MHC I complexes through UV mediated ligand exchange Nature Protocols 1 1120escr e or umans w ne omozygous or - an -  -       .   , -. ,
11322*0401 i t d ith i l t d FMDV P1 id i dwere vacc na e w a v ra vec ore -caps vacc ne an .,
b t d th l t A l i f CD8+ t t i T l h t (CTL )oos e a mon a er na ys s o cy o ox c ymp ocy es s.
f th i l h d FMDV ifi killi f i i f t d PK 15rom ese an ma s s owe spec c ng o v rus n ec e - T t t i i fe ramer s a n ng o
t t ll hi h l t h d t SLA O f th fi t t
  
arge ce s w c are a so ma c e a ne o e ve e ramers FMDV ti T ll, . reac ve ce s
generated for SLA 1 specificall stained CD8+ T cells from these accinated
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animals of the SLA *0401 genotype 8
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0Peptide length: 9u S   4    SLA 1*0401 E ti t d di ti 0 444 ( i t i hb HLA B*1517)    - : s ma e pre c on accuracy: . us ng neares ne g or -
0
0
         
M j Hi ibili C l l I (MHC I) l l hi hl 2
0SLA 2*0401: Estimated prediction accuracy: 0 393 (using nearest neighbor H2 Kk)a or stocompat ty omp ex c ass mo ecu es are g y   2-     .     -   
R k Th h ld f St Bi di tid (*SB) 0 100l hi i h bi d id d i d f h ll l i
 
 
 an res o or rong n ng pep es :po ymorp c prote ns t at n pept es er ve rom t e ce u ar prote n 0           . . 0Rank Threshold for Weak Binding peptides (*WB): 1 000
t b li ith l th f 8 11 i id Th f d i ll 0 200 400 600 800 100000 400 600 80 10 0 1 2 3 4
       . .
me a o sm w a eng o - am no ac s ey are oun n a                                                  10 10 10 10 10N bi d (*NB) i d K f 20000 M. on- n ers were ass gne a D o n
t b t d l i l l i th ll l i i t FSC H CD4
       .
ver e ra es an p ay a cruc a ro e n e ce u ar mmune response aga ns - +
i d th i t ll l th S f d MHC/ tidv ruses an o er n race u ar pa ogens ur ace expose pep e.
l t t f tid ifi MHC I t i t d t t i Tcomp exes serve as arge s or pep e-spec c res r c e cy o ox c ELISA peptide testing 0318109451-120E04,
ll E d tid th f t tl t d th ll
  
ce s n ogenous pep es ere ore are cons an y presen e on e ce 0. , ,
0
0
f i li th t t t f th i di id l ll t th i 2
0




t f th h t S ifi T ll b ti t d d kill th ll if 0
 
 
sys em o e os pec c ce s may ecome ac va e an e ce 6 0.
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B th SLA 1*0401 d SLA 2*0401 l d ll l i u  
 
 













i ll il bl i H h d th N tMHCP di t C 8
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t di t tid bi d f th t l l d f th t t d th  
 
 




tid i it i bi h i l bi di ffi it (ELISA) Id tifi d  
4
pep es n v ro us ng a oc em ca n ng a n y assay en e    .
 
 
peptide binders ere sed to generate tetramers that ere f rther tested for  
 
 






their ability to stain FMDV reactive T cells derived from pigs previously
M
0 1 2 3 4
M 10 10 10 10 100 1 2 3 4
n
M 10 10 10 10 10
vaccinated with a viral vectored FMDV P1 capsid vaccine and boosted a n T t-  T t e ramer
x




p S ifi T ll t i d b th FMDV tid t t (bl )
m
p pec c ce s s a ne y e -pep e e ramer ue versus
m
          
o
m
t i i f th T ll l ti b ti t l tido s a n ng o e same ce popu a on y a nega ve con ro pep e
C
o             
C t t (f Eb l i bl k) FITC l b l d ti CD4 ( l 74 12A h [
C e ramer rom o a v rus ac a e e an - c one - -pproac    , .     4) d PE l b l d ti CD8 ( l 76 2 11) bt i d f BDan a e e an - c one - - were o a ne rom           
(C lif i USA)(i) Select peptide sequences of interest within the FMDV A24 structural a orn a, .           
protein (P1) region using known binding motifs for the SLA 1*0401-         
allele
C l ionc us on
(ii) Run chosen peptide sequences through the NetMHCpan predictor [P tid ] M        ep e n 
algorithm to identify the peptides which are predicted to bind NetMHCpan predicted nine possible 9mer and 10mer peptide sequences                  
that would bind SLA 1*0401 and ten for SLA 2*0401 with nine of ten- - ,Selected peptides were tested and their KD binding values determined             
(iii) Perform ELISA based testing of the predicted peptide binders to predicted to bind both molecules Five of the predicted peptides bound
         
          .using a streptavidin/biotin interaction based ELISA catching correctly
f f
           
identi y true binders rom non binders SLA 1*0401 at significant binding affinities and four peptides bound SLA
        
    -  - -folded SLA complexes via the β2m using anti β2m monoclonal          , -
2*0401 One of the five tetramers generated for SLA 1 specifically stained
         
. -antibody
(i ) P d SLA i FMDV d i d SLA 1*0401 id
           .
v ro uce -tetramers us ng er ve - pept e CD8+ T cells from these vaccinated animals The four other SLA 1       . -
bi d
           
n ers tetramers and the four generated for SLA 2 showed marginal reactivity      -    . 
These data indicate that we have identified a porcine FMDV specific T cell             
( ) St i FMD ti T ll f i l i t d i iv a n reac ve ce s rom prev ous y vacc na e p gs us ng epitope that may be immunodominant for animals of the SLA *0401                   -  
SLA/FMDV tid t t-pep e e ramers genotype . 
